Nuvation Bio
NUVB
NUVB
160 hedge funds and large institutions have $526M invested in Nuvation Bio in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.69% more ownership
Funds ownership: 56.07% → 58.75% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $952K
Holders
160
Holding in Top 10
5
Calls
$3K
Puts
$952K
Top Buyers
| 1 | +$42.7M | |
| 2 | +$13.1M | |
| 3 | +$13M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$11.1M |
| 5 |
BlackRock
New York
|
+$4.17M |
Top Sellers
| 1 | -$44M | |
| 2 | -$7.9M | |
| 3 | -$2.79M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.54M |
| 5 |
Renaissance Technologies
New York
|
-$1.23M |